Article
Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors.
Nature communications - 6 Dec 2019
Gusach Anastasiia, Luginina Aleksandra, Marin Egor, Brouillette Rebecca L, Besserer-Offroy Élie, Longpré Jean-Michel, Ishchenko Andrii, Popov Petr, Patel Nilkanth, Fujimoto Taku, Maruyama Toru, Stauch Benjamin, Ergasheva Margarita, Romanovskaia Daria, Stepko Anastasiia, Kovalev Kirill, Shevtsov Mikhail, Gordeliy Valentin, Han Gye Won, Katritch Vsevolod, Borshchevskiy Valentin, Sarret Philippe, Mishin Alexey, Cherezov Vadim
Abstract excerpt
Cysteinyl leukotriene G protein-coupled receptors CysLT1 and CysLT2 regulate pro-inflammatory responses associated with allergic disorders. While selective inhibition of CysLT1R has been used for treating asthma and associated diseases for over two decades, CysLT2R has recently started to emerge as a potential drug target against atopic asthma, brain injury and central nervous system disorders, as well as several...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
